A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...
Digging deep into the molecular mechanisms behind ALS, researchers at the Les Turner ALS Center at Northwestern Medicine have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results